Answers are grounded in this paper and cite their sources.
This project develops a less invasive ventricular assist device to improve blood flow in cardiogenic shock.
A less invasive paracorporeal single port pulsatile ventricular assist device (sppVAD) was developed for cardiogenic shock.This compact sppVAD includes a valved single lumen cannula (VSLC), valveless single port diaphragm displacement pump (spDDP), and portable console.A 33/27 Fr VSLC was fabricated for mock loop testing, a 28/25 Fr VSLC was made for 6 hr sheep testing (n=5, 44-52 kg), and valveless spDDP with portable console was made.The sppVAD (33/27 Fr VSLC) achieved 6.2 L/min flow in mock loop.In sheep, the 28/25 Fr VSLC was inserted without cardiopulmonary bypass from apex to ascending aorta within 1 min after apex exposure.The sppVAD achieved 3.75 L/min flow in sheep with stable hemodynamics.Hemoglobin, free hemoglobin, and platelet/white blood cell counts were unchanged through 6 hrs.Thus, our less invasive sppVAD achieved total left ventricle support with acceptable short-term hemocompatibility, showing good promise as a temporary VAD for cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: